Vimarsana
Biggest News Aggregation in the World

Generic Design Assessment News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Generic Design Assessment. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Generic Design Assessment Today - Breaking & Trending Today

Facility to demonstrate Rolls-Royce SMR module production : New Nuclear - Vimarsana News

Facility to demonstrate Rolls-Royce SMR module production : New Nuclear

Rolls-Royce SMR has announced plans for a facility in Sheffield, South Yorkshire, UK, to manufacture and test prototype modules for its small modular reactors.

Funds awarded to assist Xe-100 deployment in the UK : New Nuclear - Vimarsana News

Funds awarded to assist Xe-100 deployment in the UK : New Nuclear

X-energy and Cavendish Nuclear have been granted GBP3.34 million (USD4.23 million) in funding from the UK government to develop plans for the deployment of X-energy's Xe-100 high temperature gas-cooled reactor in the country.

Nuclear: Media serves up another round of climate denialism - Vimarsana News

Nuclear: Media serves up another round of climate denialism

The media needs to stop treating nonsensical claims about nuclear power from the Coalition seriously and do some basic fact-checking.

The Engineer - Mott MacDonald signs small modular reactor agreement - Vimarsana News

The Engineer - Mott MacDonald signs small modular reactor agreement

Mott MacDonald has signed a Memorandum of Understanding with Holtec Britain and Hyundai E&C to explore the delivery of Holtec’s Small Modular Reactor (SMR) technology in the UK.

Rolls-Royce delivers a record performance in 2023, strong momentum into 2024 - Vimarsana News

Rolls-Royce delivers a record performance in 2023, strong momentum into 2024

Rolls-Royce Holdings plc (LON:RR) reports strong 2023 results with £1.6bn operating profit and 10.3% margin. CEO Tufan Erginbilgic highlights transformation success and 2024 guidance.